Guru Ownership Trend
Guru Analysis for Protagonist Therapeutics, Inc. (PTGX)
Protagonist Therapeutics, Inc. (PTGX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $39.36 M.
Top institutional holders include Ken Fisher and Stanley Druckenmiller.
Institutional sentiment is currently Bullish. This is evidenced by a $1.44 M net inflow during the quarter.
Recent activity highlights Ken Fisher who increased their stake by 167.2%. Conversely, John Hussman reduced exposure by 16.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Protagonist Therapeutics, Inc. (PTGX)
Major holders include Ken Fisher ($18.34 M), Stanley Druckenmiller ($16.83 M), Joel Greenblatt ($2.23 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 396,825 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.44 M, with 3 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 4 fully exited PTGX. The total reported sell value was $11.1 M.
Yes, 1 managers opened new positions in PTGX, and 2 increased their existing holdings. The total reported buy value was $12.55 M.
